News and breakthroughs in tissue analysis, biomarkers, and pathology technology.
Flagship publishes article on using IHC and digital imaging to improve patient selection for PD-L1 therapy
First NSCLC study using cTA to report IHC data in immuno-oncology Westminster, CO, June 7, 2018 – Flagship is proud to co-author the research paper,
Flagship Participates in ASCO Annual Meeting 2018
Download Flagship ASCO booth map Westminster, CO, May 23, 2018 – Flagship Biosciences will participate in the largest annual gathering of oncology professionals and researchers
Flagship to Present Computational Tissue Analysis Solutions for Advancing Drug Development at AACR Annual Meeting
Download Flagship AACR reference Westminster, CO, April 12, 2018 – Flagship Biosciences’ cTA® and decision support platform will be featured in four scientific poster presentations
Flagship Receives Accreditation from College of American Pathologists
Westminster, CO, April 10, 2018 – The Accreditation Committee of the College of American Pathologists (CAP) has awarded accreditation to Flagship Biosciences, based on results
Flagship Biosciences ActionAnalysis Solutions Accelerate Drug Development
Ready-to-use and custom image analysis meets current and future development needs Westminster, CO, February 12, 2018 – Flagship Biosciences is adding to its menu of
Flagship supports Summit Therapeutics advancement of DMD therapies
January 26, 2018 – Flagship is proud to partner with Summit Therapeutics in its efforts to advance therapies for patients with Duchenne Muscular Dystrophy (DMD).
